More than 50 percent of biopharmaceutical companies are adversely affected by manufacturing bottlenecks due to capacity and production purification problems. Compounding this challenge is the increasingly global demand for new protein-based drugs. To help overcome these production bottlenecks, Pall Corporation (NYSE: PLL) is launching two new chromatography sorbents that provide a novel approach to protein purification.
The Pall BioSepra® PPA and HEA HyperCel? mixed-mode sorbents equip process chromatographers with entirely new chemistries and new separation options for purifying proteins for higher yield and recovery under selected conditions. These environmentally friendly sorbents do not require lyotropic or other salt additives, thereby reducing harmful processing conditions that can lead to protein aggregation and impact stability. This contributes to cost savings by reducing and/or eliminating the expenses associated with salt recycling and waste disposal.
The Pall BioSepra® PPA and HEA HyperCel? mixed-mode chromatography sorbents will be introduced at Achema in Frankfurt, Germany, May 15-19, 2006 in Hall 6, Stand E12-E15.
These technologies will also be highlighted at Pall's press conference at Achema on Wednesday, May 17, at 11.00 a.m. in Esprit Room in Hall 9.1.